A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
This study has been designed to evaluate the efficacy and safety of a 20-mg dose of tadalafil
administered "on demand" to patients with erectile dysfunction (ED) after external-beam
radiotherapy (EBRT) of prostate cancer.